National Diabetes Audit
National Diabetes Audit
The National Diabetes Audit (NDA) is the largest annual clinical audit in the world, integrating data from both primary and secondary care sources, making it the most comprehensive audit of its kind.
2015-2016 Audit Collection
Preparation is currently under way for the 2015-2016 audit collection. The provisional dates for submission are 20th June to 29th July 2016. We are currently working with the clinical systems to set up the collection and develop 'How to Guidance' for submissions. Please check this page regularly for updates and register your details with the NDA team to receive the latest information.
New Reporting Format for the National Diabetes Audit
Report 1: Care Processes and Treatment Targets for 2013-14 and 2014-15 was published on 28 January 2016. This year we published the main report as a PowerPoint presentation to help CCGs and diabetes leads disseminate the findings locally. We also published GP practice and specialist unit reports. The report can be found here http://www.hscic.gov.uk/pubs/ndauditcorerep1415
Have Your Say
This is the first year the audit has reported in this way and we would like your feedback. We have developed an online survey which should take approximately five minutes to complete. If you would like to view the questions prior to completing the online survey they can be downloaded here Report 1 Online Survey Questions [99kb]
Link to online survey: https://www.surveymonkey.co.uk/r/National_Diabetes_Audit_Format_Feedback
Lessons Learned from 2013-14 and 2014-15
Following the drop in GP practice participation for 2013-14 and 2014-15 the National Diabetes Team have been busy gathering feedback from Clinical Commissioning Groups (CCGs), Strategic Clinical Networks (SCNs) and GP practices to find out what the barriers were to participation and what helped enable practices to participate in the audit. It is hoped that the results of this feedback will help CCGs, SCNs and GP practices to participate in future years of the NDA. We have produced two documents, the main report that details the full findings and recommendations and a summary document that contains the key information.
Both the full report and the summary document can be found under Guidance for CCGs and Clinical Networks on the right hand side of this page
What does it measure?
The National Diabetes Audit is a major national clinical audit, which measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. The NDA collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes.
The National Diabetes Audit (NDA) answers four key questions based on the diabetes National Service Framework (NSF):
- Is everyone with diabetes diagnosed and recorded on a practice diabetes register?
- What percentage of people registered with diabetes received the nine NICE key processes of diabetes care?
- What percentage of people registered with diabetes achieved NICE defined treatment targets for glucose control, blood pressure and blood cholesterol?
- For people with registered diabetes what are the rates of acute and long term complications (disease outcomes)?
Aims and Objectives
The NDA aims to improve the quality of patient care by enabling NHS organisations to:
- compare their outcomes of care with similar NHS organisations
- identify and share best practice
- identify gaps or shortfalls in commissioning services
- assess local practice against NSF for diabetes and NICE guidelines and drive service improvement
- provide a more comprehensive picture of diabetes care and outcomes in England and Wales
Through participation in the audit, local services are able to benchmark their performance and identify where they are performing well, and improve the quality of treatment and care they provide. On a national level, wide participation in the audit also provides an overview of the quality of care being provided in England and Wales.
Who manages the audit?
The National Diabetes Audit (NDA) is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit Programme (NCA) and delivered by the Health and Social Care Information Centre in partnership with Diabetes UK and the National Cardiovascular Intelligence Network (part of Public Health England). The NDA receives expert input from clinicians and people with diabetes across England and Wales
Analysing your data
A series of reports are available in the catalogue that will provide you with information on:
- Audit participation in primary and secondary care
Data tables with information:
- care processes (percentage recorded)
- HbA1c results
- patient age distribution
- average age and BMI
- diabetes type distribution
- ketoacidosis episodes
Further in-depth analysis at a national and local level on:
- registration and prevalence
- care processes
- treatment targets
Data Access Requests
Please submit NDA data access requests to the audit commissioner, HQIP, using the following link:
Use of Audit Tools and Documentation Outside of the Clinical Audit
You hereby agree that in downloading or using the documents or tools on this web page for any use outside of the project for which it was developed, you are entering into a royalty free, non-exclusive, licence agreement with the Healthcare Quality Improvement Partnership under the following Terms and Conditions:
All information, software, products and related graphics contained in the audit tool or data collection form are provided for non commercial purposes "as is" without warranty, including but not limited to the implied warranties of satisfactory quality, fitness for a particular purpose, title and non-infringement of third party intellectual property rights. In no event shall HQIP be liable for any direct, indirect, incidental, special or consequential damages for loss of profits, revenue, data or use incurred by you or any third party, whether in action in contract, tort, or otherwise, arising from your access to, or use of, the audit tool or form. HQIP make no representations about the suitability, reliability, or timeliness, and accuracy of the information, software, products and related graphics contained in the audit tool or forms. HQIP reserves the right to make improvements, changes or updates to forms or tools at any time without notice.
Guidance for patients
Access the audit reports
Guidance for GP Practices
- NDA GP Letter [143kb]
- Further Information for GPs [25kb]
- Poster for Practices [161kb]
- Fair Processing [2Mb]
- 10 reasons why GP practices should participate in the NDA [178kb]
Guidance for Specialist Services
- To follow
Guidance for CCGs and Clinical Networks
- Lessons Learned from 2013-2015 and Plans for Improvement in England [678kb]
- Summary of lessons learned from 2013-2015 [889kb]
- Maximising participation in the NDA - CCG guidance [276kb]
- Healthcare Quality Improvement Partnership (HQIP) (external)
- Diabetes UK (external)
- Association of British Clinical Diabetologists (ABCD) (external)
- Royal College of Paediatrics and Child Health (through the National Diabetes Paediatric Audit (external)
- National Diabetes Information Service (external)